News
APLI Appili Therapeutics, Inc. (TOR)
-
- Last: 0.04
- Change: 0.00 (0.00%)
| InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Highlights ADI-100 Developments in Weekly Update Featuring Leadership Team — Comtex09:48 AM ET 05/02/2025 May 02, 2025 (Investor Brand Network via COMTEX News Network) -- Aditxt (NASDAQ: ADTX) announced that Chief Innovation Officer Dr. Shahrokh Shabahang and Adimune Co-CEO Dr. Friedrich Kapp will... |
| InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Advances Autoimmune Therapy Following Positive Mayo Clinic Study on ADI-100 — Comtex09:59 AM ET 04/14/2025 Apr 14, 2025 (Investor Brand Network via COMTEX News Network) -- Aditxt (NASDAQ: ADTX) announced that a Mayo Clinic-led study has validated preclinical findings for ADI-100, the lead autoimmune... |
| InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Regains Nasdaq Compliance and Previews Strategic Updates — Comtex09:08 AM ET 04/11/2025 Apr 11, 2025 (Investor Brand Network via COMTEX News Network) -- Aditxt (NASDAQ: ADTX) a social innovation platform focused on advancing health innovations, announced that its latest Aditxt Weekly... |
| InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Regains Nasdaq Compliance, Hearing Canceled — Comtex09:43 AM ET 04/09/2025 Apr 09, 2025 (Investor Brand Network via COMTEX News Network) -- Aditxt (NASDAQ: ADTX) announced it has regained compliance with Nasdaq's minimum bid price requirement under Listing Rule... |
| InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) to Host Appili CEO in April 4 Update Focused on Infectious Disease Innovation — Comtex09:40 AM ET 04/02/2025 Apr 02, 2025 (Investor Brand Network via COMTEX News Network) -- Aditxt (NASDAQ: ADTX), a social innovation platform accelerating health breakthroughs, announced that Don Cilla, Pharm.D., M.B.A.,... |
| InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Highlights CaSe Platform Acquisition in Weekly Update Focused on Early Cancer Detection — Comtex09:44 AM ET 03/28/2025 Mar 28, 2025 (Investor Brand Network via COMTEX News Network) -- Aditxt (NASDAQ: ADTX), a social innovation platform focused on accelerating health technologies, announced that its latest Aditxt... |
| InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Provides Update on Appili Therapeutics Acquisition and Federal Funding Applications — Comtex09:58 AM ET 03/18/2025 Mar 18, 2025 (Investor Brand Network via COMTEX News Network) -- Aditxt (NASDAQ: ADTX) through its wholly owned subsidiary Adivir, Inc., is progressing with its planned acquisition of Appili... |
| BioMedNewsBreaks -- Aditxt Inc. (NASDAQ: ADTX) Provides Corporate Update, Announces Weekly Investor Series — Comtex11:53 AM ET 03/17/2025 Mar 17, 2025 (Investor Brand Network via COMTEX News Network) -- Aditxt (NASDAQ: ADTX), a health innovation platform, provided a corporate update highlighting progress across its subsidiaries and... |
Quotes delayed at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement.